- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
 |
 |
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Sample Application
Anti-VWCE/ URG11/ VWC1 functional antibody
Anti-VWCE/ URG11/ VWC1 functional antibody for cell culture, ELISA & in-vivo assay
Go to VWCE/VWCE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
SDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1369-Ab-1/ GM-Tg-hg-SE1369-Ab-2 | Anti-Human VWCE monoclonal antibody | Human |
| GM-Tg-rg-SE1369-Ab-1/ GM-Tg-rg-SE1369-Ab-2 | Anti-Rat VWCE monoclonal antibody | Rat |
| GM-Tg-mg-SE1369-Ab-1/ GM-Tg-mg-SE1369-Ab-2 | Anti-Mouse VWCE monoclonal antibody | Mouse |
| GM-Tg-cynog-SE1369-Ab-1/ GM-Tg-cynog-SE1369-Ab-2 | Anti-Cynomolgus/ Rhesus macaque VWCE monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1369-Ab-1/ GM-Tg-felg-SE1369-Ab-2 | Anti-Feline VWCE monoclonal antibody | Feline |
| GM-Tg-cang-SE1369-Ab-1/ GM-Tg-cang-SE1369-Ab-2 | Anti-Canine VWCE monoclonal antibody | Canine |
| GM-Tg-bovg-SE1369-Ab-1/ GM-Tg-bovg-SE1369-Ab-2 | Anti-Bovine VWCE monoclonal antibody | Bovine |
| GM-Tg-equg-SE1369-Ab-1/ GM-Tg-equg-SE1369-Ab-2 | Anti-Equine VWCE monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-SE1369-Ab-1/ GM-Tg-hg-SE1369-Ab-2; GM-Tg-rg-SE1369-Ab-1/ GM-Tg-rg-SE1369-Ab-2; GM-Tg-mg-SE1369-Ab-1/ GM-Tg-mg-SE1369-Ab-2; GM-Tg-cynog-SE1369-Ab-1/ GM-Tg-cynog-SE1369-Ab-2; GM-Tg-felg-SE1369-Ab-1/ GM-Tg-felg-SE1369-Ab-2; GM-Tg-cang-SE1369-Ab-1/ GM-Tg-cang-SE1369-Ab-2; GM-Tg-bovg-SE1369-Ab-1/ GM-Tg-bovg-SE1369-Ab-2; GM-Tg-equg-SE1369-Ab-1/ GM-Tg-equg-SE1369-Ab-2 |
| Products Name | Anti-VWCE monoclonal antibody |
| Format | mab |
| Target Name | VWCE |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category of antibody | FACS/Biofunctional Antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-VWCE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | GM-Tg-g-SE1369-Ag-1 | Recombinant multi-species VWCE/ URG11/ VWC1 protein |
Target information
| Target ID | GM-SE1369 |
| Target Name | VWCE |
| Gene ID | 220001,71768,309209,694385,483801,101083799,787487,100059568 |
| Gene Symbol and Synonyms | 1300015B04Rik,RGD1309910,URG11,VWC1,VWCE |
| Uniprot Accession | Q96DN2 |
| Uniprot Entry Name | VWCE_HUMAN |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | |
| Disease | N/A |
| Gene Ensembl | ENSG00000167992 |
| Target Classification | N/A |
The target: VWCE, gene name: VWCE, also named as URG11, VWC1. Predicted to enable calcium ion binding activity. Involved in cellular response to virus. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s TaurusTM and LIBRATM platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
